Surface Oncology Inc (SURF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2022 | 12-2021 | 09-2021 | 06-2021 | 03-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 6,199 | -78,485 | -54,435 | -34,542 | -15,561 |
| Depreciation Amortization | 523 | 2,376 | 1,780 | 1,159 | 548 |
| Accounts receivable | -30,000 | N/A | N/A | N/A | N/A |
| Accounts payable and accrued liabilities | 1,074 | -226 | -1,234 | -487 | 642 |
| Other Working Capital | -32,913 | 2,109 | -2,979 | -4,328 | -7,540 |
| Other Operating Activity | 31,551 | 11,882 | 10,381 | 6,969 | 2,948 |
| Operating Cash Flow | $-23,566 | $-62,344 | $-46,487 | $-31,229 | $-18,963 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -35 | -120 | -52 | N/A | N/A |
| Purchase Of Investment | N/A | -111,632 | -91,439 | -81,311 | -70,634 |
| Sale Of Investment | 12,500 | 12,500 | 2,000 | 0 | 0 |
| Investing Cash Flow | $12,465 | $-99,252 | $-89,491 | $-81,311 | $-70,634 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | 10,687 | N/A | N/A | N/A |
| Common Stock Issued | 20,713 | 31,813 | 21,685 | 20,734 | 14,982 |
| Financing Cash Flow | $20,713 | $42,500 | $21,685 | $20,734 | $14,982 |
| Beginning Cash Position | 57,640 | 176,736 | 176,736 | 176,736 | 176,736 |
| End Cash Position | 67,252 | 57,640 | 62,443 | 84,930 | 102,121 |
| Net Cash Flow | $9,612 | $-119,096 | $-114,293 | $-91,806 | $-74,615 |
| Free Cash Flow | |||||
| Operating Cash Flow | -23,566 | -62,344 | -46,487 | -31,229 | -18,963 |
| Capital Expenditure | -35 | -120 | -52 | 0 | 0 |
| Free Cash Flow | -23,601 | -62,464 | -46,539 | -31,229 | -18,963 |